Comparative molecular docking analysis of carbapenem antibiotics with NDM-1 and OXA-23 Β-lactamases: Insights into binding mechanisms
| dc.authorid | 0000-0003-1721-0314 | |
| dc.authorid | 0000-0002-6414-9336 | |
| dc.contributor.author | Sarıyer, Emrah | |
| dc.contributor.author | Ağırbaş, Gamze | |
| dc.date.accessioned | 2026-07-09T08:41:41Z | |
| dc.date.available | 2026-07-09T08:41:41Z | |
| dc.date.issued | 2025 | |
| dc.department | AÇÜ, Sağlık Hizmetleri Meslek Yüksekokulu, Tıbbi Hizmetler ve Teknikler Bölümü | |
| dc.description.abstract | Objective: This study aimed to investigate the molecular interactions between carbapenem antibiotics (imipenem and meropenem) and two (3-lactamase enzymes, NDM-1 (class B) and OXA-23 (class D), to understand the structural basis of carbapenem resistance. Methods: The study employed molecular docking methods using the crystal structures and homology models of the NDM-1 and OXA-23 enzymes to analyze binding affinities and interaction patterns. Results: The results revealed distinct binding characteristics for each enzyme. NDM-1 exhibited a polar, hydrophobic active site, with imipenem forming hydrogen bonds with ASP124, ASN220, and LYS211, while meropenem relied on weaker interactions like Van der Waals forces. In contrast, OXA-23 featured a hydrophobic cavity with charged residues, where imipenem bonded with ARG259 and meropenem interacted with SER79, TRP219, and ARG259. A key finding was the significantly lower binding energy for the OXA-23-imipenem complex in the crystal structure (-8.06 kcal/mol) compared to its homology model (-5.34 kcal/mol), highlighting the importance of accurate structural representation. The study demonstrated strong agreement between the computational and experimental data. Conclusion: These findings provide critical insights into the structural basis of carbapenem resistance, offering potential avenues for designing inhibitors to combat (3-lactamase-mediated antibiotic resistance. The integrated approach validates the utility of computational methods in elucidating molecular interactions and guiding therapeutic strategies. | |
| dc.identifier.doi | 10.33808/clinexphealthsci.1675807 | |
| dc.identifier.endpage | 660 | |
| dc.identifier.issn | 2459-1459 | |
| dc.identifier.issue | 3 | |
| dc.identifier.startpage | 654 | |
| dc.identifier.uri | https://hdl.handle.net/11494/6295 | |
| dc.identifier.volume | 15 | |
| dc.identifier.wos | WOS:001593250700025 | |
| dc.identifier.wosquality | Q4 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.institutionauthor | Sarıyer, Emrah | |
| dc.institutionauthor | Ağırbaş, Gamze | |
| dc.institutionauthorid | 0000-0003-1721-0314 | |
| dc.institutionauthorid | 0000-0002-6414-9336 | |
| dc.language.iso | en | |
| dc.publisher | MARMARA UNIV | |
| dc.relation.ispartof | CLINICAL AND EXPERIMENTAL HEALTH SCIENCES | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | NDM-1 | |
| dc.subject | OXA-23 | |
| dc.subject | Imipenem | |
| dc.subject | Meropenem | |
| dc.subject | Molecular docking | |
| dc.title | Comparative molecular docking analysis of carbapenem antibiotics with NDM-1 and OXA-23 Β-lactamases: Insights into binding mechanisms | |
| dc.type | Article |












